Navigation Links
USHIFU, LLC Completes Acquisition of Focus Surgery, Inc.
Date:7/2/2008

prostate cancer, including Canada, Mexico, the Dominican Republic and the Bahamas, to make the non invasive therapy available. USHIFU is also funding FDA-approved clinical trials in the United States to gather data important for analysis of the technology by the FDA. The first is a pivotal trial for the treatment of primary organ confined prostate cancer that will enroll 466 participants at 24 different centers. A second pivotal trial will begin for the treatment of recurrent prostate cancer in men who have failed external beam radiation therapy. This single arm study will enroll 202 participants at 10 different sites.

About the Sonablate(R) 500

The Sonablate(R) 500 is a non-invasive medical device that utilizes ultrasound energy to destroy tissue within the body. It was developed by FSI and is manufactured by Misonix, Inc. (Nasdaq: MSON) who also holds distribution rights in Europe. Takai Hospital Supply Ltd. and THS International distribute the Sonablate(R) 500 in Southeast Asia and the Middle East.

The Sonablate(R) 500 is not approved for use in the U.S. The Sonablate(R) 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate(R) 500 for the treatment of prostate cancer.


'/>"/>
SOURCE USHIFU, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
2. KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
3. Beeston completes drilling on Bluff Lake property, 100 Mile House
4. PreMD Successfully Completes Project for Health & Beauty Company
5. Sinexus Welcomes New CEO and Completes Series B
6. ACTS Retirement-Life Communities Completes Carlton Cove Acquisition
7. Health Fitness Completes Share Repurchase Plan
8. Lockheed Martin Completes Acquisition of Eagle Group International, LLC
9. The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009
10. Mindray Medical Completes Acquisition of Datascopes Patient Monitoring Business
11. Takeda Completes Acquisition of Millennium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Aflac Incorporated announced today that it ... senior notes with a coupon of 6.9%. The ... 98.951 to yield 6.984%. The company anticipates using ... and general corporate purposes. ,, Commenting on the ... and Chief Financial Officer Kriss Cloninger III commented: ...
(Date:12/14/2009)... found simple activities like housework, gardening replaced tube watching ... was watching 25 or 26 hours of television a ... him to cut his tube time in half. , ... more calories each day, and not necessarily through strenuous ... Much of his newly freed time was spent reading ...
(Date:12/14/2009)... NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The ... the largest survey on teen drug abuse tracking over ... teens, intentional abuse of prescription (Rx) and over-the-counter (OTC) ... an alarming number of young people abusing medicines they ... Teen Abuse of Medication Continues to Be a Pervasive ...
(Date:12/14/2009)... BOSTON, Dec. 14 When Kurth Krause, ... crew instructions for landing on the moon, he,was ... about anything.,Years later, Kurth realized there was one ... a kidney transplant and even though dialysis machines,would ... without a transplant. Kurth,wrote: "My wife is 69 ...
(Date:12/14/2009)... San Diego School of Medicine and Osaka University in ... liver damage, including inflammation, fibrosis and cancer. The findings ... TAK1, works could lead to new insights into the ... appears to be a master regulator of liver function," ... Dean of the UC San Diego School of Medicine. ...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Cutting TV Time Burns More Calories 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Scientists uncover protective mechanism against liver cancer 2
... Financing Led by Clarus Ventures -MOUNT OLIVE, N.J., Jan ... development of programmable implantable pumps for targeted delivery of ... $25 million.Clarus Ventures, a life sciences venture capital firm, ... investment by FatBoy Capital, LP. In conjunction with ...
... generation of health and longevity products with ... & mineral supplement concentrate. AimCa++DONAN is ideal ... in pre and post-menopausal phases, baby-boomers, and ... products of Aim Pharmakon are highly efficacious ...
... STOCKHOLM, January 12 Sweden The Swedish investment,company Karolinska ... Oy that develops stem cell and other tissue engineering ... In 2007 EvoStem Finland Oy introduced its ... service for tendon and ligament injuries,in horses. TendoStem(R) is ...
... HotHead Technologies, Inc., an,Atlanta-based enterprise committed to ... it is working closely with Schutt,Sports to ... which can,detect potential heat stroke in a ... activities was officially announced at the American ...
... scientific study in which victims of a brain injury were more ... of spirituality might actually be caused by brain damage among victims ... ... Denver, CO (PRWEB) January 11, 2009 -- LegalView, the most ...
... bacteria in King Nut brand; almost 400 Americans in 42 ... 10(HealthDay News) -- Health officials in the state of Minnesota ... one brand of peanut butter distributed to schools and hospitals, ... has struck in 42 states so far. , Officials from ...
Other Medicine News:Health News:InSet Technologies Completes $25 Million Financing 2Health News:AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate 2Health News:AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate 3Health News:AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate 4Health News:Karolinska Development Invests in EvoStem Finland Oy 2Health News:HotHead Technologies Working with Schutt Sports to Develop 'Smart' Helmet 2Health News:HotHead Technologies Working with Schutt Sports to Develop 'Smart' Helmet 3Health News:LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage 2Health News:LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage 3Health News:LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage 4Health News:Peanut Butter Eyed as Source of Salmonella Outbreak 2Health News:Peanut Butter Eyed as Source of Salmonella Outbreak 3
(Date:12/14/2009)... 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. ... had received a complete response letter from the ... its New Drug Application ("NDA") for Onrigin(TM) (laromustine) ... indicates that the FDA cannot approve the Company,s ... to address remaining issues. ,, Alan Kessman, Chief ...
(Date:12/14/2009)... -- Cancer patients in Finland have gained access ... RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: ... radiotherapy clinic in the Nordic region. Clinicians at ... and precise form of radiotherapy to treat patients ... abdomen and prostate. ,, RapidArc, which enables clinicians ...
(Date:12/14/2009)... 14 According to Millennium Research Group ... intelligence, increased use of safety devices for small-bore ... a key driver of the enteral feeding device ... new US and European Markets for Enteral ... giving set segment will experience the greatest impact ...
Breaking Medicine Technology:Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab 28R 29 Systems for the Cost Efficient Development of Biopharmaceuticals 12812 1Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab 28R 29 Systems for the Cost Efficient Development of Biopharmaceuticals 12812 2Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab 28R 29 Systems for the Cost Efficient Development of Biopharmaceuticals 12812 3Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab 28R 29 Systems for the Cost Efficient Development of Biopharmaceuticals 12812 4Jillian Michaels Americas Toughest Trainer Announces New Line of Weight Loss Supplements 50243 1Jillian Michaels Americas Toughest Trainer Announces New Line of Weight Loss Supplements 50243 2Jillian Michaels Americas Toughest Trainer Announces New Line of Weight Loss Supplements 50243 3Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti diuretic Effect in Phase IIa Trial in Nocturia 4662 1Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti diuretic Effect in Phase IIa Trial in Nocturia 4662 2Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti diuretic Effect in Phase IIa Trial in Nocturia 4662 3
... /PRNewswire-FirstCall/ --,Phosphagenics Limited (AIM: PSG) announced today ... 1b clinical trial to demonstrate the,efficacy and ... transdermal,insulin product, TPM-02/Insulin, containing long-acting insulin.,The trial ... quarter of,2007. , TPM-02/Insulin gel is being ...
... to be Part of Data Package Required to ... -- Novavax,Inc. said today that it has received ... ferrets inoculated with its pandemic,influenza vaccine, paving the ... this year. , In the study, ferrets were ...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 2Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: